The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Heparin and Other Glycosaminoglycans Stimulate the Formation of Amyloid Fibrils from α-Synuclein in Vitro
Abstract
Parkinson's disease is the second most common neurodegenerative disease and results from loss of dopaminergic neurons in the substantia nigra. The aggregation and fibrillation of alpha-synuclein have been implicated as a causative factor in the disease. Glycosaminoglycans (GAGs) are routinely found associated with amyloid deposits in most amyloidosis diseases, and there is evidence to support an active role of GAGs in amyloid fibril formation in some cases. In contrast to the extracellular amyloid deposits, the alpha-synuclein deposits in Lewy body diseases are intracellular, and thus it is less clear whether GAGs may be involved. To determine whether the presence of GAGs does affect the fibrillation of alpha-synuclein, the kinetics of fibril formation were investigated in the presence of a number of GAGs and other charged polymers. Certain GAGs (heparin, heparan sulfate) and other highly sulfated polymers (dextran sulfate) were found to significantly stimulate the formation of alpha-synuclein fibrils. Interestingly, the interaction of GAGs with alpha-synuclein is quite specific, since some GAGs, e.g., keratan sulfate, had negligible effect. Heparin not only increased the rate of fibrillation but also apparently increased the yield of fibrils. The molar ratio of heparin to alpha-synuclein and the incorporation of fluorescein-labeled heparin into the fibrils demonstrate that the heparin is integrated into the fibrils and is not just a catalyst for fibrillation. The apparent dissociation constant for heparin in stimulating alpha-synuclein fibrillation was 0.19 microM, indicating a strong affinity. Similar effects of heparin were observed with the A53T and A30P mutants of alpha-synuclein. Since there is some evidence that Lewy bodies may contain GAGs, these observations may be very relevant in the context of the etiology of Parkinson's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levine, H. (1993) · Protein Science · doi:10.1002/pro.5560020312 · Cited by 2,264
Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes
Davidson, W. S., Jonas, A., Clayton, D. F., & George, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9443 · Cited by 1,585
Conway, K. A., Lee, S.-J., Rochet, J.-C., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,541
NACP, A Protein Implicated in Alzheimer's Disease and Learning, Is Natively Unfolded
Weinreb, P. H., Zhen, W., Poon, A. W., Conway, K. A., & Lansbury, P. T. (1996) · Biochemistry · doi:10.1021/bi961799n · Cited by 1,523
Conway, K. A., Harper, J. D., & Lansbury, P. T. (1998) · Nature Medicine · doi:10.1038/3311 · Cited by 1,499
Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.
Uéda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J., Ihara, Y., & Saitoh, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11282 · Cited by 1,480
Molecular modeling of protein-glycosaminoglycan interactions.
Cardin, A. D., & Weintraub, H. J. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.1.21 · Cited by 1,301
Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine T
Naiki, H., Higuchi, K., Hosokawa, M., & Takeda, T. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90046-8 · Cited by 1,223
Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation
Uversky, V. N., Li, J., & Fink, A. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010907200 · Cited by 1,096
Self-citationIdentification of two distinct synucleins from human brain
Jakes, R., Spillantini, M. G., & Goedert, M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00395-5 · Cited by 1,080
Goedert, M., Jakes, R., Spillantini, M. G., Hasegawa, M., Smith, M. J., & Crowther, R. A. (1996) · Nature · doi:10.1038/383550a0 · Cited by 1,036 · cited 4×
“... seen with dermatan sulfate and chondroitin-4-sulfate, followed by (in decreasing order) heparan sulfate, keratan sulfate, and heparin ( 7). For tau aggregation, the strongest effect was seen with heparin, dextran sulfate, and pentosan sulfate, followed by heparan sulfate and RNA, with weak stimulation by dermatan…”
BackgroundInfluentialMurphy, D. D., Rueter, S. M., Trojanowski, J. Q., & Lee, V. M.-Y. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03214.2000 · Cited by 836
Conway, K. A., Harper, J. D., & Lansbury, P. T. (2000) · Biochemistry · doi:10.1021/bi991447r · Cited by 786
Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation
Serpell, L. C., Berriman, J., Jakes, R., Goedert, M., & Crowther, R. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4897 · Cited by 748
α-Synuclein Fibrillogenesis Is Nucleation-dependent
Wood, S. J., Wypych, J., Steavenson, S., Louis, J.-C., Citron, M., & Biere, A. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19509 · Cited by 720
Both Familial Parkinson's Disease Mutations Accelerate α-Synuclein Aggregation
Narhi, L., Wood, S. J., Steavenson, S., Jiang, Y., Wu, G. M., Anafi, D., Kaufman, S. A., Martin, F., Sitney, K., Denis, P., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9843 · Cited by 710
α-Synuclein Membrane Interactions and Lipid Specificity
Jo, E., McLaurin, J., Yip, C. M., St. George-Hyslop, P., & Fraser, P. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004345200 · Cited by 604
Li, J., Uversky, V. N., & Fink, A. L. (2001) · Biochemistry · doi:10.1021/bi010616g · Cited by 513
Self-citationBinding of α-Synuclein to Brain Vesicles Is Abolished by Familial Parkinson's Disease Mutation
Jensen, P. H., Nielsen, M. S., Jakes, R., Dotti, C. G., & Goedert, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26292 · Cited by 511
Giasson, B. I., Uryu, K., Trojanowski, J. Q., & Lee, V. M.-Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7619 · Cited by 507
Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions
Engelender, S., Kaminsky, Z., Guo, X., Sharp, A. H., Amaravi, R. K., Kleiderlein, J. J., Margolis, R. L., Troncoso, J. C., Lanahan, A. A., Worley, P. F., et al. (1999) · Nature Genetics · doi:10.1038/8820 · Cited by 489
Interaction of Human α-Synuclein and Parkinson's Disease Variants with Phospholipids
Perrin, R. J., Woods, W. S., Clayton, D. F., & George, J. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004851200 · Cited by 432
Jenco, J. M., Rawlingson, A., Daniels, B., & Morris, A. J. (1998) · Biochemistry · doi:10.1021/bi972776r · Cited by 431
Synthetic filaments assembled from C‐terminally truncated α‐synuclein
Crowther, R. A., Jakes, R., Spillantini, M. G., & Goedert, M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01146-6 · Cited by 417
Pérez, M., Valpuesta, J. M., Medina, M., Montejo de Garcini, E., & Avila, J. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67031183.x · Cited by 411
Jensen, P. H., Hager, H., Nielsen, M. S., Højrup, P., Gliemann, J., & Jakes, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25481 · Cited by 377
Friedhoff, P., Schneider, A., Mandelkow, E.-M., & Mandelkow, E. (1998) · Biochemistry · doi:10.1021/bi980537d · Cited by 373
Phosphorylation of microtubule‐associated protein tau by stress‐activated protein kinases
Goedert, M., Hasegawa, M., Jakes, R., Lawler, S., Cuenda, A., & Cohen, P. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00483-3 · Cited by 305
Trojanowski, J. Q., Goedert, M., Iwatsubo, T., & Lee, V. M.-Y. (1998) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400432 · Cited by 297
Hashimoto, M., Hsu, L. J., Sisk, A., Xia, Y., Takeda, A., Sundsmo, M., & Masliah, E. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00514-9 · Cited by 267
McLaurin, J., Franklin, T., Zhang, X., Deng, J., & Fraser, P. E. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00957.x · Cited by 258
El-Agnaf, O. M. A., Jakes, R., Curran, M. D., & Wallace, A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01419-7 · Cited by 258
Alpha‐synuclein in Lewy Body Disease and Alzheimer's Disease
Hashimoto, M., & Masliah, E. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00552.x · Cited by 254
Castillo, G. M., Ngo, C., Cummings, J., Wight, T. N., & Snow, A. D. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69062452.x · Cited by 234
Castillo, G. M., Lukito, W., Wight, T. N., & Snow, A. D. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721681.x · Cited by 223
Rochet, J.-C., Conway, K. A., & Lansbury, P. T. (2000) · Biochemistry · doi:10.1021/bi001315u · Cited by 222
Chaperone‐like activity of synucleins
Souza, J. M., Giasson, B. I., Lee, V. M.-Y., & Ischiropoulos, H. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01563-5 · Cited by 221
Review: Modulating Factors in Amyloid-β Fibril Formation
McLaurin, J., Yang, D.-S., Yip, C. M., & Fraser, P. E. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4289 · Cited by 218
Alzheimer-like Changes in Microtubule-associated Protein Tau Induced by Sulfated Glycosaminoglycans
Hasegawa, M., Crowther, R. A., Jakes, R., & Goedert, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.52.33118 · Cited by 203
Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques
Ginsberg, S. D., Crino, P. B., Lee, V. M. ‐., Eberwine, J. H., & Trojanowski, J. Q. (1997) · Annals of Neurology · doi:10.1002/ana.410410211 · Cited by 189
Biere, A. L., Wood, S. J., Wypych, J., Steavenson, S., Jiang, Y., Anafi, D., Jacobsen, F. W., Jarosinski, M. A., Wu, G.-M., Louis, J.-C., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005514200 · Cited by 178
Proteoglycan-mediated Inhibition of Aβ Proteolysis
Gupta-Bansal, R., Frederickson, R. C. A., & Brunden, K. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.31.18666 · Cited by 176
Cotman, S. L., Halfter, W., & Cole, G. J. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0816 · Cited by 173
Goedert, M. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0466 · Cited by 172
Circular-dichroism studies on two murine serum amyloid A proteins
McCubbin, W. D., Kay, C. M., Narindrasorasak, S., & Kisilevsky, R. (1988) · Biochemical Journal · doi:10.1042/bj2560775 · Cited by 165
Hasegawa, M., Jakes, R., Crowther, R. A., Lee, V. M.-Y., Ihara, Y., & Goedert, M. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00271-2 · Cited by 163
RNA sequestration to pathological lesions of neurodegenerative diseases
Ginsberg, S. D., Galvin, J. E., Chiu, T.-L. S., Lee, V. M. ‐., Masliah, E., & Trojanowski, J. Q. (1998) · Acta Neuropathologica · doi:10.1007/s004010050923 · Cited by 142
Heparin-binding Properties of the Amyloidogenic Peptides Aβ and Amylin
Watson, D. J., Lander, A. D., & Selkoe, D. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31617 · Cited by 135
Jensen, P. H., Islam, K., Kenney, J. M., Nielsen, M. S., Power, J., & Gai, W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000099200 · Cited by 134
Review: Amyloidogenesis—Unquestioned Answers and Unanswered Questions
Kisilevsky, R. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4222 · Cited by 127
Snow, A. D., Kinsella, M. G., Parks, E., Sekiguchi, R., Miller, J., Kimata, K., & Wight, T. N. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1345 · Cited by 123
pH‐Dependent Binding of Synthetic β‐Amyloid Peptides to Glycosaminoglycans
Brunden, K. R., Richter‐Cook, N. J., Chaturvedi, N., & Frederickson, R. C. A. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb07453.x · Cited by 117
Structural prerequisites for serum amyloid A fibril formation.
de Beer, M. C., de Beer, F. C., McCubbin, W. D., Kay, C. M., & Kindy, M. S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80768-6 · Cited by 94
Brandt, R., Lee, G. S., Teplow, D. B., Shalloway, D. I., & Abdel-Ghany, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32639-x · Cited by 91
Clarris, H. J., Cappai, R., Heffernan, D., Beyreuther, K. T., Masters, C. L., & Small, D. H. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68031164.x · Cited by 85
Co-deposition of basement membrane components during the induction of murine splenic AA amyloid.
Lyon, A. W., Narindrasorasak, S., Young, I. D., Anastassiades, T., Couchman, J., McCarthy, K. J., & Kisilevsky, R. (1991) · PubMed · Cited by 83
Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide
Buée, L., Ding, W., Delacourte, A., & Fillit, H. M. (1993) · Brain Research · doi:10.1016/0006-8993(93)91706-x · Cited by 82
Effect of amino‐acid substitutions on Alzheimer's amyloid‐β peptide–glycosaminoglycan interactions
McLaurin, J., & Fraser, P. E. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01725.x · Cited by 81
Multhaup, G. (1994) · Biochimie · doi:10.1016/0300-9084(94)90163-5 · Cited by 74
Mawal-Dewan, M., SEN, P. C., Abdel-Ghany, M., Shalloway, D. I., & Racker, E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41832-7 · Cited by 66
Buée, L., Ding, W., Anderson, J. P., Narindrasorasak, S., Kisilevsky, R., Boyle, N. J., Robakis, N. K. R. K., Delacourte, A., Greenberg, B., & Fillit, H. M. (1993) · Brain Research · doi:10.1016/0006-8993(93)90321-d · Cited by 66
Ailles, L., Kisilevsky, R., & Young, I. D. (1993) · PubMed · Cited by 62
Yang, S., Yu, J., Shiah, S., & Huang, J. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63041416.x · Cited by 55
Basic fibroblast growth factor binds to filamentous inclusions of neurodegenerative diseases
Perry, G. L., Richey, P. L., Siedlak, S. L., Galloway, P. G., Kawai, M., & Cras, P. P. (1992) · Brain Research · doi:10.1016/0006-8993(92)90074-j · Cited by 44
Schulz, J. B., & DICHGANS, J. (1999) · Current Opinion in Neurology · doi:10.1097/00019052-199908000-00010 · Cited by 39
Atoji, Y., Yamamoto, Y., & Suzuki, Y. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11447-5 · Cited by 10
Structural Properties of the Heparin-Binding Domains of Human Apolipoprotein E
Cardin, A. D., & Jackson, R. L. (1988) · Advances in experimental medicine and biology · doi:10.1007/978-1-4613-0733-4_19 · Cited by 6
Cited by
Gaggelli, E., Kozlowski, H., Valensin, D., & Valensin, G. (2006) · Chemical Reviews · doi:10.1021/cr040410w · Cited by 1,729
Functional Amyloids As Natural Storage of Peptide Hormones in Pituitary Secretory Granules
Maji, S. K., Perrin, M. H., Sawaya, M. R., Jessberger, S., Vadodaria, K., Rissman, R. A., Singru, P. S., Nilsson, K. P. R., Simon, R., Schubert, D., et al. (2009) · Science · doi:10.1126/science.1173155 · Cited by 1,048
Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds
Holmes, B. B., DeVos, S. L., Kfoury, N., Li, M., Jacks, R., Yanamandra, K., Ouidja, M. O., Brodsky, F. M., Marasa, J., Bagchi, D. P., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301440110 · Cited by 859
Neuropathology, biochemistry, and biophysics of α‐synuclein aggregation
Uversky, V. N. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04764.x · Cited by 567
Self-citationWhat Macromolecular Crowding Can Do to a Protein
Kuznetsova, I., Turoverov, K., & Uversky, V. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151223090 · Cited by 564
Self-citation
Metadata
- Authors
- Cohlberg, J. A., Li, J., Uversky, V. N., & Fink, A. L.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2002-01-11
- Volume
- 41
- Issue
- 5
- Pages
- 1502-1511
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2014485936
- Cited by
- 340
- References
- 67
- FWCI
- 8.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.